Uptake of BRCA 1/2 and oncotype DX testing by medical and surgical oncologists

Overview of attention for article published in Breast Cancer Research and Treatment, May 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

So far, Altmetric has seen 10 X posts from 9 X users, with an upper bound of 27,774 followers.

Uptake of BRCA 1/2 and oncotype DX testing by medical and surgical oncologists #BCSM @MGHCancerCenter #precisionmedicine https://t.co/h85aOr0dW9

RT @LguzzardiM: Uptake of #BRCA 1/2 and ⁦@Oncotype_Breast⁩ DX testing by medical & surgical oncologists ⁦@BasserBRCA⁩ ⁦@MassGeneralNews⁩…

RT @LguzzardiM: Uptake of #BRCA 1/2 and ⁦@Oncotype_Breast⁩ DX testing by medical & surgical oncologists ⁦@BasserBRCA⁩ ⁦@MassGeneralNews⁩…

RT @LguzzardiM: Uptake of #BRCA 1/2 and ⁦@Oncotype_Breast⁩ DX testing by medical & surgical oncologists ⁦@BasserBRCA⁩ ⁦@MassGeneralNews⁩…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.